Treatments for pancreatic cancer

Details for Australian Patent Application No. 2005244154 (hide)

Owner FibroGen, Inc.

Inventors Neff, Thomas B.; Spong, Suzanne M.; Klaus, Stephen J.

Agent FB Rice

Pub. Number AU-B-2005244154

PCT Pub. Number WO2005/110479

Priority 60/588,843 16.07.04 US; 60/566,277 28.04.04 US

Filing date 28 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 4 February 2010

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/110479 Priority application(s): WO2005/110479

4 February 2010 Application Accepted

  Published as AU-B-2005244154

11 March 2010 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 17 Feb 2010. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

1 July 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 17 Feb 2010

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244157-HIV integrase inhibitors

2005244153-Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections